Demo Sign up Log In

GSK plc American Depositary Shares (Each representing two Ordinary Shares) (GSK)

R&D Expenses

£9.20B

TTM · Period ending: Jun 30, 2026 · GBP

GSK R&D Expenses

Latest reported£9.20B GBPperiod endingJun 30, 2026

Latest reported£9.20B GBPperiod endingJun 30, 2026

GSK TTM R&D Expenses · GBP (£0.00 → £9.20B)

TTM R&D Expenses

High-resolution chart · PNG

GSK r&d expenses history

Trailing twelve months (TTM) · GBP. Each value covers four complete reported quarters.

GSK plc American Depositary Shares (Each representing two Ordinary Shares) R&D Expenses — Trailing twelve months (TTM) (GBP)
Period ending	R&D Expenses (GBP)
Jun 30, 2001	2,619,000,000
Mar 31, 2001	2,580,000,000
Dec 31, 2000	2,526,000,000
Sep 30, 2000	1,797,000,000
Jun 30, 2000	1,158,000,000
Mar 31, 2000	838,980,000
Dec 31, 1999	297,980,000
Sep 30, 1999	297,980,000
Jun 30, 1999	297,980,000
Mar 31, 1999	275,880,400
Dec 31, 1998	275,880,400
Sep 30, 1998	275,880,400
Jun 30, 1998	275,880,400
Mar 31, 1998	0
Dec 31, 1997	0
Sep 30, 1997	0
Jun 30, 1997	0
Mar 31, 1997	0
Dec 31, 1996	0
Sep 30, 1996	0
Jun 30, 1996	0
Mar 31, 1996	0
Sep 30, 1995	0
Jun 30, 1995	0
Mar 31, 1995	0
Dec 31, 1994	0
Sep 30, 1994	0
Jun 30, 1994	0
Mar 31, 1994	0
Dec 31, 1993	0
Sep 30, 1993	0
Jun 30, 1993	0
Mar 31, 1993	0
Dec 31, 1992	0
Sep 30, 1992	0
Jun 30, 1992	0
Mar 31, 1992	0
Dec 31, 1991	0
Sep 30, 1991	0
Jun 30, 1991	0
Mar 31, 1991	0
Dec 31, 1990	0
Sep 30, 1990	0
Jun 30, 1990	0
Mar 31, 1990	0
Dec 31, 1989	0
Sep 30, 1989	0
Jun 30, 1989	0
Mar 31, 1989	0
Dec 31, 1988	0
Sep 30, 1988	0
Jun 30, 1988	0
Mar 31, 1988	0
Dec 31, 1987	0
Sep 30, 1987	0
Jun 30, 1987	0
Mar 31, 1987	0
Dec 31, 1986	0
Sep 30, 1986	0
Jun 30, 1986	0

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.